000289190 001__ 289190
000289190 005__ 20250401145635.0
000289190 0247_ $$2doi$$a10.1007/s40273-024-01365-z
000289190 0247_ $$2pmid$$apmid:38551803
000289190 0247_ $$2ISSN$$a1170-7690
000289190 0247_ $$2ISSN$$a1179-2027
000289190 0247_ $$2altmetric$$aaltmetric:161419904
000289190 037__ $$aDKFZ-2024-00624
000289190 041__ $$aEnglish
000289190 082__ $$a610
000289190 1001_ $$0P:(DE-He78)cc3ecd7dfed30d3a52cb6ed61d19782a$$aMuchadeyi, Muchandifunga$$b0$$eFirst author$$udkfz
000289190 245__ $$aQuality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations.
000289190 260__ $$aBerlin [u.a.]$$bSpringer$$c2024
000289190 3367_ $$2DRIVER$$aarticle
000289190 3367_ $$2DataCite$$aOutput Types/Journal article
000289190 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1718626170_4718
000289190 3367_ $$2BibTeX$$aARTICLE
000289190 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000289190 3367_ $$00$$2EndNote$$aJournal Article
000289190 500__ $$a#EA:C100#LA:C100# / 2024 Jul;42(7):767-782
000289190 520__ $$aThe increasing number of studies that generate health state utility values (HSUVs) and the impact of HSUVs on cost-utility analyses make a robust tailored quality appraisal (QA) tool for systematic reviews of these studies necessary.This study aimed to address conceptual issues regarding QA in systematic reviews of studies eliciting HSUVs by establishing a consensus on the definitions, dimensions and scope of a QA tool specific to this context.A modified Delphi method was used in this study. An international multidisciplinary panel of seven experts was purposively assembled. The experts engaged in two anonymous online survey rounds. After each round, the experts received structured and controlled feedback on the previous phase. Controlled feedback allowed the experts to re-evaluate and adjust their positions based on collective insights. Following these surveys, a virtual face-to-face meeting was held to resolve outstanding issues. Consensus was defined a priori at all stages of the modified Delphi process.The response rates to the first-round and second-round questionnaires and the virtual consensus meeting were 100%, 86% and 71%, respectively. The entire process culminated in a consensus on the definitions of scientific quality, QA, the three QA dimensions-reporting, relevance and methodological quality-and the scope of a QA tool specific to studies that elicit HSUVs.Achieving this consensus marks a pivotal step towards developing a QA tool specific to systematic reviews of studies eliciting HSUVs. Future research will build on this foundation, identify QA items, signalling questions and response options, and develop a QA tool specific to studies eliciting HSUVs.
000289190 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000289190 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000289190 7001_ $$00000-0002-6685-1903$$aHernandez-Villafuerte, Karla$$b1
000289190 7001_ $$00000-0002-5470-3567$$aDi Tanna, Gian Luca$$b2
000289190 7001_ $$0P:(DE-He78)9600624b0539f0fa9344e8936954b93d$$aEckford, Rachel$$b3$$udkfz
000289190 7001_ $$00000-0003-4436-1126$$aFeng, Yan$$b4
000289190 7001_ $$00000-0003-0092-5970$$aMeregaglia, Michela$$b5
000289190 7001_ $$00000-0001-8024-7801$$aPeasgood, Tessa$$b6
000289190 7001_ $$00000-0003-3121-6050$$aPetrou, Stavros$$b7
000289190 7001_ $$0P:(DE-He78)7586e13ade56c5b4d4cba2fc411b0cf0$$aUbels, Jasper$$b8$$udkfz
000289190 7001_ $$0P:(DE-He78)1f315d09721b91091df1ba78eb65cbaf$$aSchlander, Michael$$b9$$eLast author$$udkfz
000289190 773__ $$0PERI:(DE-600)2043876-X$$a10.1007/s40273-024-01365-z$$n7$$p767-782$$tPharmacoEconomics$$v42$$x1170-7690$$y2024
000289190 8564_ $$uhttps://inrepo02.dkfz.de/record/289190/files/s40273-024-01365-z.pdf
000289190 8564_ $$uhttps://inrepo02.dkfz.de/record/289190/files/s40273-024-01365-z.pdf?subformat=pdfa$$xpdfa
000289190 909CO $$ooai:inrepo02.dkfz.de:289190$$pVDB
000289190 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)cc3ecd7dfed30d3a52cb6ed61d19782a$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000289190 9101_ $$0I:(DE-588b)2036810-0$$60000-0002-6685-1903$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000289190 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9600624b0539f0fa9344e8936954b93d$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000289190 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7586e13ade56c5b4d4cba2fc411b0cf0$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000289190 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1f315d09721b91091df1ba78eb65cbaf$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000289190 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000289190 9141_ $$y2024
000289190 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-08-25$$wger
000289190 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2023-08-25$$wger
000289190 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bPHARMACOECONOMICS : 2022$$d2023-08-25
000289190 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-25
000289190 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-25
000289190 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-08-25
000289190 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-08-25
000289190 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-25
000289190 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-25
000289190 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-25
000289190 915__ $$0StatID:(DE-HGF)1180$$2StatID$$aDBCoverage$$bCurrent Contents - Social and Behavioral Sciences$$d2023-08-25
000289190 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-25
000289190 915__ $$0StatID:(DE-HGF)0130$$2StatID$$aDBCoverage$$bSocial Sciences Citation Index$$d2023-08-25
000289190 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-25
000289190 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-08-25
000289190 9202_ $$0I:(DE-He78)C100-20160331$$kC100$$lGesundheitsökonomie$$x0
000289190 9201_ $$0I:(DE-He78)C100-20160331$$kC100$$lGesundheitsökonomie$$x0
000289190 9200_ $$0I:(DE-He78)C100-20160331$$kC100$$lGesundheitsökonomie$$x0
000289190 980__ $$ajournal
000289190 980__ $$aVDB
000289190 980__ $$aI:(DE-He78)C100-20160331
000289190 980__ $$aUNRESTRICTED